Skip to main content

Atea Pharmaceuticals, Inc.

AVIR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001593899

In the last 90 days, Atea Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 126 institutions reported holding it in 13F filings for Q3 2026, worth $307.4M in total; no superinvestor holds it.

Key figures

Market capClose on Nov 19, 2026
$315.6M
Insider buysOpen market, last 90 days
0
Insider sellsLast 90 days, $168.1K in total
1
13F holdersQ3 2026, +3 vs. previous quarter
126
13F valueReported value at the end of Q3 2026
$307.4M
Superinvestors holdingAt the end of Q3 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
–
No comparable prior period
Net income, FY2025
-$158.3M
No comparable prior period
Free cash flow, FY2025
–
No comparable prior period
Revenue, Q3 FY2026
–
No comparable prior period

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
3.01M
Shares sold short
Change
−62.2K
−2.0% vs. previous
Days to cover
9.55
At average daily volume

Superinvestors holding AVIR, Q3 2026

Go to the superinvestors tab

No superinvestor reported holding AVIR at the end of Q3 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Atea Pharmaceuticals, Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 18, 2026 (view filing)8:59 PM ETNov 16-182 daysPolsky BruceDirectorSSale−41.2K$4.08−$168.1K−20.6%158.6K after3 lots
May 21, 2026 (view filing)May 183 daysMurphy Polly A.DirectorPPurchase+6.10K$4.17+$25.4K+7.1%92.1K afterAmended
Jan 17, 2025 (view filing)Jan 15-162 daysBerger Franklin MDirectorPPurchase+25.0K$3.26+$81.5K+5.5%476.9K afterAmended2 lots
Dec 12, 2024 (view filing)Dec 102 daysBerger Franklin MDirectorSSale−359.6K$2.85−$1.02M−44.3%451.9K after
Sep 19, 2024 (view filing)Sep 17-192 daysSommadossi Jean-PierrePresident, CEO, and ChairmanSSale−58.0K$4.04−$234.2K−1.0%5.87M after3 lots10b5-1
Jun 21, 2024 (view filing)Jun 201 dayPolsky BruceDirectorSSale−17.5K$3.49−$61.2K−21.1%65.6K after
Jun 7, 2024 (view filing)Jun 52 daysSommadossi Jean-PierrePresident, CEO, and ChairmanSSale−1.01K$4.00−$4.02K0.0%5.92M after10b5-1
Feb 2, 2024 (view filing)Feb 11 dayCorcoran AndreaSee RemarksSSale−15.8K$3.84−$60.8K−2.3%670.2K after
Feb 2, 2024 (view filing)Feb 11 daySommadossi Jean-PierrePresident, CEO, and ChairmanSSale−56.9K$3.85−$219.1K−32.8%116.6K after10b5-1
Feb 2, 2024 (view filing)Feb 11 dayHorga Maria ArantxaChief Medical OfficerSSale−15.9K$3.84−$60.9K−38.2%25.7K after

Top 10 13F holders, Q3 2026

See all 126 holders

The largest institutional positions in Atea Pharmaceuticals, Inc. at the end of Q3 2026; share changes are against Q2 2026.

Institutions holding AVIR in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
FMR LLC12,030,704$62.7M0.00%+26,640+0.2%Added
BlackRock, Inc.9,061,530$47.2M0.00%+341,453+3.9%Added
BML Capital Management, LLC6,753,658$35.2M18.88%−198,672−2.9%Reduced
Tang Capital Management LLC4,814,700$25.1M1.15%00.0%Unchanged
Vanguard Capital Management LLC2,906,793$15.1M0.00%−58,069−2.0%Reduced
Acadian Asset Management LLC2,338,271$12.2M0.01%+303,079+14.9%Added
Bain Capital Life Sciences Investors, LLC2,075,639$10.8M0.73%00.0%Unchanged
Geode Capital Management, LLC1,910,289$9.96M0.00%−48,146−2.5%Reduced
State Street Corp1,626,938$8.48M0.00%−25,461−1.5%Reduced
Two Sigma Investments, LP1,303,341$6.79M0.00%−203,356−13.5%Reduced

Holders of 5% or more of AVIR

See all 5 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Atea Pharmaceuticals, Inc..

Largest holders of AVIR from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
FMR LLC13G/A15.00%12.0M shares+3.40 ppfrom 11.60%Feb 8, 202110 filingsMay 6, 2026SEC
Sommadossi Jean-Pierre13G/A11.00%9.08M shares+0.90 ppfrom 10.10%Feb 10, 20216 filingsNov 13, 2026SEC
BML Investment Partners, L.P.13G9.90%7.81M shares+1.40 ppfrom 8.50%Oct 2, 20235 filingsFeb 9, 2026SEC
BlackRock, Inc.13G/A7.10%6.08M shares–Apr 23, 20251 filingApr 23, 2025SEC
Tang Capital Management LLC13G6.00%4.81M sharesNewOct 6, 20261 filingOct 6, 2026SEC